Health Care & Life Sciences » Pharmaceuticals | Hainan Haiyao Co. Ltd.

Hainan Haiyao Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
109,699.70
170,612.60
197,692.50
159,333.60
81,206.70
102,308.60
Depreciation, Depletion & Amortization
42,813.60
47,037.00
55,780.10
85,983.90
105,046.10
124,043.20
Other Funds
403,952.40
429,800.00
676,818.10
3,576,536.70
203,374.40
323,748.50
Funds from Operations
207,343.70
367,551.80
375,446.60
436,048.90
414,854.90
529,854.30
Changes in Working Capital
5.30
298,880.00
199,569.30
426,181.10
171,645.60
994,380.40
Net Operating Cash Flow
207,338.40
68,671.80
175,877.20
9,867.80
586,500.50
464,526.10
Capital Expenditures
277,873.50
225,989.60
169,266.30
175,080.80
768,095.40
Sale of Fixed Assets & Businesses
1,369.20
3,657.30
779.00
39,362.90
134,461.00
Purchase/Sale of Investments
1,109,395.00
410,220.00
635,550.00
1,712,323.30
162,546.00
Net Investing Cash Flow
434,621.10
182,659.90
688,202.60
3,748,350.80
656,020.30
Cash Dividends Paid - Total
24,759.50
24,759.50
16,360.20
-
200,396.90
Issuance/Reduction of Debt, Net
44,050.00
425,900.00
192,650.00
646,304.10
1,395,339.60
Net Financing Cash Flow
335,142.90
20,859.50
853,107.90
4,222,840.90
481,799.00
Net Change in Cash
107,625.20
230,683.40
345,078.10
489,099.40
405,928.70
Free Cash Flow
70,535.10
157,317.90
6,610.90
165,213.00
181,595.00
Deferred Taxes & Investment Tax Credit
1,328.40
3,837.20
3,503.70
6,906.60
11,121.00
20,246
Net Assets from Acquisitions
-
-
-
387,269.10
89,060.00
Other Sources
1,271,278.20
61,029.20
158,043.10
109,253.60
727,841.90
Change in Capital Stock
-
-
-
-
509,769.30
Exchange Rate Effect
235.00
211.30
4,295.60
4,741.50
6,350.40
Other Uses
320,000.00
66,257.00
42,208.40
1,622,294.10
823,713.80

About Hainan Haiyao Co.

View Profile
Address
No. 192 Nanhai Avenue
Haikou Hainan 570311
China
Employees -
Website http://www.haiyao.com.cn
Updated 07/08/2019
Hainan Haiyao Co., Ltd. engages in the research, development, manufacture and sale of medicines and medical instrument. Its products consist of six categories, including cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The company was founded in 1965 and is headquartered in Haikou, China.